Information about Swiftpharma
My details
*
*
*

Swiftpharma (SRL)

BE 0781.598.284

Thor Park 8027/215, 3600 Genk

Company information

Status
Active

Enterprise number

BE0781.598.284

VAT liability
Yes
Established
04-02-2022
Last balance sheet year
2024
Company size
Medium-sized 2,8 FTE
Principal activity
Research and development in other physical and natural sciences
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Swiftpharma

2024 2023
Profit/Loss € -1,883,926 -3402 % € 57,060
Equity € 2,585,634 4241 % € 59,560
Gross margin € -1,382,412 -517 % € 331,174
Employees 2.8 1

Publications from Swiftpharma

Date Publication
03-12-2025 Registered Office (NL)
08-10-2025 Resignations - Appointments (NL)
08-08-2025 Resignations - Appointments (NL)
10-01-2025 Resignations - Appointments (NL)
01-10-2024 Articles of Association (Translation, Coordination, Other Modifications, …) - Capital - Shares - Resignations - Appointments (NL)

Frequently asked questions

What is the VAT number of Swiftpharma?
The VAT number of Swiftpharma is BE 0781.598.284.
Wat is the PEPPOL ID of Swiftpharma?
The PEPPOL ID of Swiftpharma is 0208:0781598284. Log in or start a free trial to see the full overview.
When was Swiftpharma founded?
Swiftpharma was founded on 04-02-2022.
What is the address of Swiftpharma?
The current registered office of Swiftpharma is located at Thor Park 8027/215, 3600 Genk.
When was the last time Swiftpharma filed their annual financial statements?
The most recent financial statements of Swiftpharma were filed on 17-06-2025.
How many employees does Swiftpharma have?
There are 2,8 FTEs working at Swiftpharma according to the staff figures in the most recent financial statements.
What is the annual turnover of Swiftpharma?
At the time of its most recent financial statements, Swiftpharma did not publish any turnover figures. Swiftpharma reported a gross margin of -€1,382,411.50.

Sources